Lloyd’s approves syndicate to insure transportation of Covid-19 vaccine

Coronavirus

The syndicate-in-a-box is supported by Ascot, Axa XL and McGill and Partners.

Lloyd’s has announced the creation and in principle approval* of its newest “syndicate in a box,” Syndicate 1796, set up to insure the storage and transportation of a Covid-19 vaccine, once developed, to emerging economies.

The market said the initiative forms part of Lloyd’s response to the far-reaching impacts of the pandemic.

Syndicate 1796 has been developed by Parsyl, an insurance technology company and Lloyd’s Lab alumni, in close partnership with Ascot as managing agent, and in

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Meet the MGA: Kayzen Specialty

Kayzen Specialty founder and CEO Charles Boorman explains to Jonathan Swift his plans for the MGA to be a go-to market for financial lines through continuous improvement across its three pillars of broker-centric, underwriter-fronted and tech-focused.

i-Wonder delivers on fast food

i-Wonder, provider of niche insurance comparison website solutions, has confirmed the adoption of its offering for the UK fast food delivery sector by “one of” the UK’s main aggregators, Insurance Age can reveal.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: